120ml 10 Panel Drug Test Cup with K2, MDMA & OPI2000

120ml 10 Panel Drug Test Cup with K2, MDMA and OPI2000

The Serenity 120ml 10 panel drug test cup with K2 brings together dedicated K2/Spice and MDMA assays with eight additional drug-screening panels.

Identified by SKU SM-CDOA-1104K-FUO, this configuration includes an OPI cutoff of 2,000 ng/mL and separate panels for THC, buprenorphine and oxycodone. Each labeled assay provides its own preliminary screening result.

Choose this model when your purchasing specification calls for the listed K2 and MDMA combination in a 120ml cup. It is the larger-capacity counterpart to the 90ml K2 and MDMA version, with the same listed drug panels and cutoff levels.

Cup capacity and drug coverage are separate purchasing considerations, so selecting the larger format does not add extra screening panels.

The combination is particularly important when comparing ten-panel products. Some alternatives include methadone, fentanyl or EtG in different panel arrangements. This SKU includes K2 and MDMA without dedicated fentanyl or methadone assays.

Matching the complete configuration helps you select the product that covers the substances specified in your testing procedure.

Before ordering, compare the panel list, cutoff values, capacity and labeled intended use. The table below identifies this product’s complete configuration, while our 10 panel drug test cup collection provides access to other combinations.

For repeat purchases, use the SKU to distinguish this 120ml cup from similarly named products.

10 Panel Drug Test Cup with K2 Cutoff Levels

The following table lists the ten drug panels and their screening cutoffs for SM-CDOA-1104K-FUO. These thresholds are product specifications; the cup does not provide a numerical measurement of the drug concentration in an individual sample.

Understanding the K2, MDMA and OPI2000 Panels

K2 and THC are separate assays in this configuration. Although each lists a 50 ng/mL cutoff, they target different substances and must be interpreted separately. The K2 panel should not be treated as coverage for every synthetic cannabinoid; consult the matching insert for the compounds evaluated, cross-reactivity and limitations.

MDMA also has its own panel, separate from the MET methamphetamine assay. Read the drug abbreviation beside each result area rather than combining the findings from similarly named substances.

For an OPI2000 drug test, the number identifies the listed opiate screening cutoff of 2,000 ng/mL. This differs from an OPI/300 configuration. Buprenorphine and oxycodone have separate assays, so the OPI result should not be used as a result for every opioid.

Compare the 120ml K2 Cup with Other Ten-Panel Options

Use the required cup capacity and drug combination to narrow your selection:

• Same listed panels in a smaller cup: compare the 90ml K2 and MDMA drug test cup. It lists the same ten assays and cutoffs in a different-capacity format.
• A 120ml option with methadone: review the 120ml MDMA and methadone cup with OPI2000. That configuration includes MTD in place of K2.
• K2 with kratom, EtG and fentanyl: compare the 120ml K2, kratom, EtG and fentanyl cup. It has a different ten-panel combination, so review its complete drug list before substituting products.

A larger capacity does not establish a different cutoff, additional drug coverage or a particular specimen fill requirement. Follow the specifications and instructions for the exact product you order.

How to Read 10 Panel Drug Test Results

For the competitive drug-assay lines, use the control region marked C and the test region marked T. Interpret every labeled assay separately within the reading window specified in the supplied instructions.

A faint colored test line counts as a test line when the control line is present and the result is read within the specified window. Line darkness does not measure drug concentration.

If the control line is missing, the affected assay is invalid even when a test line appears. Review the procedure and repeat with a new device as directed by the insert. Do not report an invalid assay as negative or non-negative.

Screening results are preliminary. A non-negative result should be confirmed using an appropriate laboratory method, and a negative result does not establish that every drug is absent. For additional examples, read our guide to how to read a drug test cup.

Order the 120ml K2 and MDMA Cup by SKU

Use SM-CDOA-1104K-FUO when ordering this 120ml configuration. Including the SKU, cup capacity and K2/MDMA combination helps identify the correct product when comparing supplies or requesting a quote.

Review the quantity pricing displayed on this page for your order size. For larger purchases, request wholesale drug testing supply pricing with the product code, number of cups and delivery destination.

Frequently Asked Questions

What does OPI2000 mean on this drug test cup?

OPI2000 identifies the opiate panel and its listed screening cutoff of 2,000 ng/mL. It is a different cutoff from an OPI/300 configuration and does not provide a numerical measurement of the drug concentration in a sample.

Does this K2 and MDMA cup include fentanyl or methadone?

No dedicated fentanyl or methadone panel is listed for SM-CDOA-1104K-FUO. Its ten panels are AMP, BUP, BZO, COC, K2, MDMA, MET, OPI, OXY and THC.

Does the K2 panel detect every synthetic cannabinoid?

No universal coverage should be assumed. Check the matching product insert for the compounds evaluated by the K2 assay, cross-reactivity and limitations. The separate THC panel does not replace the K2 assay.

Does the 120ml cup test for more drugs than the 90ml version?

No. The 120ml and 90ml K2 and MDMA versions list the same ten drug panels and cutoff levels. They have different cup capacities, and each should be used according to its supplied instructions.

How much specimen does the 120ml cup require?

Use the specimen volume specified in the matching package insert. The 120ml specification describes cup capacity and should not be treated as the required collection volume.

What if a control line does not appear?

The affected assay is invalid, whether or not a test line appears. Review the testing procedure and repeat with a new device as directed by the insert. Do not report an invalid assay as negative or non-negative.